Trial · NCT05284448
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | improvement in liver aminotransferases(ALT and AST) | 6 months compared to the baseline | Difference between last and first measurements |
| Primary | NAFLD fibrosis score (NFS) | 6 months compared to the baseline | Change in NAFLD fibrosis score (NFS) (lower score means better outcome). |
| Secondary | The Aspartate (AST) to Platelet Ratio Index (APRI) score: | 6 months compared to the baseline | Change in (APRI) score (lower score means better outcome). |
| Secondary | The Fibrosis-4 (FIB-4) values: | 6 months compared to the baseline | Change in (FIB-4) values (lower values means better outcome). |
| Secondary | Serum Alkaline Phosphatase level (ALP) | 6 months compared to the baseline | Change in ALP serum level as inflammatory markers of NASH |
| Secondary | Serum Gamma-glutamyl Transferase level (GGT) | 6 months compared to the baseline | Change in GGT serum level as inflammatory markers of NASH |
| Secondary | Serum total and direct bilirubin. | 6 months compared to the baseline | Change in levels of serum total and direct bilirubin. |
| Secondary | Waist circumference | 6 months compared to the baseline | Change in waist circumference |
| Secondary | Change in anthropometric measures | 6 months compared to the baseline | including BMI etc. |
| Secondary | Lipid profile | 6 months compared to the baseline | Change in serum lipids |
| Secondary | Glycated hemoglobin (HbA1C) | 6 months compared to the baseline | Change in HbA1C level for patients with T2DM |
| Secondary | Fasting blood glucose level | 6 months compared to the baseline | Change in fasting blood glucose for patients with T2DM |
| Secondary | Drugs adverse events | 6 months compared to the baseline | Assessment of safety by reporting any adverse events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05284448/registered